Medy-Tox Inc.

₩64,000As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:086900Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (14.54%)
Div yield 1.88%
ROE 3.59%
Biotechnology
Beta (5Y) 0.36
PE TTM 28.60
TSR TTM (45.79%)
Mkt cap ₩413.3B
ROIC 3.71%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩62,098
(2.97%)
(68.96%)
Hold 10|1|9|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
800.96
773.28
816.53
831.00
17.92%
8.13%
10.10%
4.51%
Revenue₩B
35.30
34.88
36.59
38.26
7.52%
7.70%
13.23%
12.27%
Peers (US$304.7M)
Cap (US$)
PE
317.3M
—
244.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.786
(0.677)
(0.504)
EBIT/Intx
0.377
0.451
0.455
Own earn%
69.48
(102.96)
(82.68)
Sh yield%
11.08
13.69
14.23
Owners
Insiders/Inst%
14.58
48.96
Short interest%
4.04
SBC / revenue%
1.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
6–16
$1 testx
—
Incr. ROIC%
4